Surgery can be curative in non-small-cell lung cancer, but has only a
minor role in small-cell lung cancer. About two-thirds of patients wit
h non-small-cell lung cancer present with advanced disease that cannot
be treated surgically. Lymph node involvement alone does not indicate
inoperable or incurable cancer. Lobectomy in patients with Stage I di
sease results in a five-year survival rate of 70%. Lobectomy or pneumo
nectomy with resection of involved nodes in patients with Stage II dis
ease has a five-year survival rate of 40%-45%. Carefully selected pati
ents with Stage IIIA disease may benefit from surgical treatment.